table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Healthcare-associated Infectious Disease Diagnostics Market Size Analysis from 2023 to 2028
1.5.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Healthcare-associated Infectious Disease Diagnostics Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Healthcare-associated Infectious Disease Diagnostics Industry Impact
Chapter 2 Global Healthcare-associated Infectious Disease Diagnostics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Healthcare-associated Infectious Disease Diagnostics (Volume and Value) by Type
2.1.1 Global Healthcare-associated Infectious Disease Diagnostics Consumption and Market Share by Type (2017-2022)
2.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue and Market Share by Type (2017-2022)
2.2 Global Healthcare-associated Infectious Disease Diagnostics (Volume and Value) by Application
2.2.1 Global Healthcare-associated Infectious Disease Diagnostics Consumption and Market Share by Application (2017-2022)
2.2.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue and Market Share by Application (2017-2022)
2.3 Global Healthcare-associated Infectious Disease Diagnostics (Volume and Value) by Regions
2.3.1 Global Healthcare-associated Infectious Disease Diagnostics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Healthcare-associated Infectious Disease Diagnostics Consumption by Regions (2017-2022)
4.2 North America Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.10 South America Healthcare-associated Infectious Disease Diagnostics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Healthcare-associated Infectious Disease Diagnostics Market Analysis
5.1 North America Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
5.1.1 North America Healthcare-associated Infectious Disease Diagnostics Market Under COVID-19
5.2 North America Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
5.3 North America Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
5.4 North America Healthcare-associated Infectious Disease Diagnostics Consumption by Top Countries
5.4.1 United States Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
5.4.2 Canada Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
5.4.3 Mexico Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 6 East Asia Healthcare-associated Infectious Disease Diagnostics Market Analysis
6.1 East Asia Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
6.1.1 East Asia Healthcare-associated Infectious Disease Diagnostics Market Under COVID-19
6.2 East Asia Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
6.3 East Asia Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
6.4 East Asia Healthcare-associated Infectious Disease Diagnostics Consumption by Top Countries
6.4.1 China Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
6.4.2 Japan Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
6.4.3 South Korea Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 7 Europe Healthcare-associated Infectious Disease Diagnostics Market Analysis
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
7.1.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Under COVID-19
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
7.4 Europe Healthcare-associated Infectious Disease Diagnostics Consumption by Top Countries
7.4.1 Germany Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
7.4.2 UK Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
7.4.3 France Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
7.4.4 Italy Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
7.4.5 Russia Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
7.4.6 Spain Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
7.4.7 Netherlands Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
7.4.8 Switzerland Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
7.4.9 Poland Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 8 South Asia Healthcare-associated Infectious Disease Diagnostics Market Analysis
8.1 South Asia Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
8.1.1 South Asia Healthcare-associated Infectious Disease Diagnostics Market Under COVID-19
8.2 South Asia Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
8.3 South Asia Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
8.4 South Asia Healthcare-associated Infectious Disease Diagnostics Consumption by Top Countries
8.4.1 India Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
8.4.2 Pakistan Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Analysis
9.1 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
9.1.1 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Under COVID-19
9.2 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
9.3 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
9.4 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Consumption by Top Countries
9.4.1 Indonesia Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
9.4.2 Thailand Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
9.4.3 Singapore Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
9.4.4 Malaysia Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
9.4.5 Philippines Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
9.4.6 Vietnam Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
9.4.7 Myanmar Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 10 Middle East Healthcare-associated Infectious Disease Diagnostics Market Analysis
10.1 Middle East Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
10.1.1 Middle East Healthcare-associated Infectious Disease Diagnostics Market Under COVID-19
10.2 Middle East Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
10.3 Middle East Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
10.4 Middle East Healthcare-associated Infectious Disease Diagnostics Consumption by Top Countries
10.4.1 Turkey Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
10.4.3 Iran Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
10.4.5 Israel Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
10.4.6 Iraq Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
10.4.7 Qatar Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
10.4.8 Kuwait Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
10.4.9 Oman Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 11 Africa Healthcare-associated Infectious Disease Diagnostics Market Analysis
11.1 Africa Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
11.1.1 Africa Healthcare-associated Infectious Disease Diagnostics Market Under COVID-19
11.2 Africa Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
11.3 Africa Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
11.4 Africa Healthcare-associated Infectious Disease Diagnostics Consumption by Top Countries
11.4.1 Nigeria Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
11.4.2 South Africa Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
11.4.3 Egypt Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
11.4.4 Algeria Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
11.4.5 Morocco Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 12 Oceania Healthcare-associated Infectious Disease Diagnostics Market Analysis
12.1 Oceania Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
12.2 Oceania Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
12.3 Oceania Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
12.4 Oceania Healthcare-associated Infectious Disease Diagnostics Consumption by Top Countries
12.4.1 Australia Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
12.4.2 New Zealand Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 13 South America Healthcare-associated Infectious Disease Diagnostics Market Analysis
13.1 South America Healthcare-associated Infectious Disease Diagnostics Consumption and Value Analysis
13.1.1 South America Healthcare-associated Infectious Disease Diagnostics Market Under COVID-19
13.2 South America Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Types
13.3 South America Healthcare-associated Infectious Disease Diagnostics Consumption Structure by Application
13.4 South America Healthcare-associated Infectious Disease Diagnostics Consumption Volume by Major Countries
13.4.1 Brazil Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
13.4.2 Argentina Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
13.4.3 Columbia Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
13.4.4 Chile Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
13.4.5 Venezuela Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
13.4.6 Peru Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
13.4.8 Ecuador Healthcare-associated Infectious Disease Diagnostics Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Healthcare-associated Infectious Disease Diagnostics Business
14.1 Abbott
14.1.1 Abbott Company Profile
14.1.2 Abbott Healthcare-associated Infectious Disease Diagnostics Product Specification
14.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Luminex
14.2.1 Luminex Company Profile
14.2.2 Luminex Healthcare-associated Infectious Disease Diagnostics Product Specification
14.2.3 Luminex Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 bioMrieux
14.3.1 bioMrieux Company Profile
14.3.2 bioMrieux Healthcare-associated Infectious Disease Diagnostics Product Specification
14.3.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Accelerate Diagnostics
14.4.1 Accelerate Diagnostics Company Profile
14.4.2 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product Specification
14.4.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 F. Hoffmann-La Roche
14.5.1 F. Hoffmann-La Roche Company Profile
14.5.2 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product Specification
14.5.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 BD
14.6.1 BD Company Profile
14.6.2 BD Healthcare-associated Infectious Disease Diagnostics Product Specification
14.6.3 BD Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 OpGen
14.7.1 OpGen Company Profile
14.7.2 OpGen Healthcare-associated Infectious Disease Diagnostics Product Specification
14.7.3 OpGen Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 DiaSorin Molecular
14.8.1 DiaSorin Molecular Company Profile
14.8.2 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product Specification
14.8.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Bio-Rad
14.9.1 Bio-Rad Company Profile
14.9.2 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Specification
14.9.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Meridian Bioscience
14.10.1 Meridian Bioscience Company Profile
14.10.2 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product Specification
14.10.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Danaher
14.11.1 Danaher Company Profile
14.11.2 Danaher Healthcare-associated Infectious Disease Diagnostics Product Specification
14.11.3 Danaher Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 QIAGEN
14.12.1 QIAGEN Company Profile
14.12.2 QIAGEN Healthcare-associated Infectious Disease Diagnostics Product Specification
14.12.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Trinity Biotech
14.13.1 Trinity Biotech Company Profile
14.13.2 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product Specification
14.13.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Quidel
14.14.1 Quidel Company Profile
14.14.2 Quidel Healthcare-associated Infectious Disease Diagnostics Product Specification
14.14.3 Quidel Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Thermo Fisher Scientific
14.15.1 Thermo Fisher Scientific Company Profile
14.15.2 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Specification
14.15.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Healthcare-associated Infectious Disease Diagnostics Market Forecast (2023-2028)
15.1 Global Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Healthcare-associated Infectious Disease Diagnostics Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Healthcare-associated Infectious Disease Diagnostics Value and Growth Rate Forecast (2023-2028)
15.2 Global Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Healthcare-associated Infectious Disease Diagnostics Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Healthcare-associated Infectious Disease Diagnostics Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Healthcare-associated Infectious Disease Diagnostics Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Healthcare-associated Infectious Disease Diagnostics Consumption Forecast by Type (2023-2028)
15.3.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Forecast by Type (2023-2028)
15.3.3 Global Healthcare-associated Infectious Disease Diagnostics Price Forecast by Type (2023-2028)
15.4 Global Healthcare-associated Infectious Disease Diagnostics Consumption Volume Forecast by Application (2023-2028)
15.5 Healthcare-associated Infectious Disease Diagnostics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
